We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05224141
Brief Title: Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008)

First Submitted : January 25, 2022
First Submitted that Met QC Criteria : January 25, 2022
First Posted : February 4, 2022

Last Update Submitted that Met QC Criteria : March 3, 2023
Last Update Posted : March 7, 2023